TransCode publishes preclinical data on glioblastoma treatment
Go back to TransCode publishes preclinical data on glioblastoma treatment| (NASDAQ: RNAZ) | Delayed: 8.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.56 | 52 Week High | $ | |||
| Open | $8.56 | 52 Week Low | $ | |||
| Day High | $8.56 | P/E | N/A | |||
| Day Low | $8.56 | EPS | $ | |||
| Volume | 264 | |||||

